Clinical Efficacy
The Paxman Scalp Cooling system is globally recognized as the leading product for hair-loss prevention during chemotherapy treatment.
Having carried out extensive clinical trials and device refinement, we have created a system that is clinically proven, cost-effective and widely embraced by physicians, nurses and patients alike.
RANDOMIZED
US TRIAL
OUR GLOBAL
STUDIES
Extensive Global Experience:
Since 2003, more than 65 clinical studies have been conducted in more than 17 countries including: Australia, Austria, Canada, Denmark, France, Germany, Greece, India, Italy, Japan, Lebanon, Netherlands, Norway, Sweden, Switzerland, UK and the US.
100000
PATIENTS TREATED
40
AVAILABLE MARKETS
20
YEARS IN USE
65
STUDIES WORLDWIDE
Research and Development
We are leading the way in research to ensure a better understanding of scalp cooling. The more we know, the more we can guide the development of our system and cap, and the more effective a treatment scalp cooling can become.
Find out more about how we are chasing zero hair loss during chemotherapy at the Paxman Research & Innovation Centre, the first of its kind in the world.
